<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date08008814.9 (espacenet)  (Federated)  (European Patent Register), 20041116
Patent/reg. no. and dateDK/EP 1983000, 20150902
Publication date20081022
Priority no. and dateGB 0327181, 20031121, GB 0417115, 20040730
EP pub. no. and date EP 1983000 20081022
Effective date
Applicant/ownerUCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE
Applicant ref. no.159229
InventorRAPECKI, Stephen Edward, UCB Celltech
208 Bath Road

Slough Berkshire SL1 3WE, GB,
Christie, Mark Ian, UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Mead, Richard James, UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Robinson, Martyn Kim, UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC ClassA61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61K 47/48 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) , C07K 16/28 (2006.01) 
TitleFremgangsmåde til behandling af multipel sklerose ved inhibering af IL-17-aktivitet
Int. application no.
Int. publication no.
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact